Your browser doesn't support javascript.
loading
Clinical outcomes of cyclin-dependent kinase 4-6 (CDK 4-6) inhibitors in patients with male breast cancer: A multicenter study.
Yildirim, Hasan Çagri; Mutlu, Emel; Chalabiyev, Elvin; Özen, Miraç; Keskinkiliç, Merve; Ön, Sercan; Çelebi, Abdussamet; Dursun, Bengü; Acar, Ömer; Kahraman, Seda; Aykan, Musa Baris; Kaman, Ömür; Dogan, Akif; Erdogan, Atike Pinar; Melisa Celayir, Özde; Günenç, Damla; Güven, Deniz Can; Vedat Bayoglu, Ibrahim; Yavuzsen, Tugba; Hacibekiroglu, Ilhan; Inanç, Mevlüde; Kiliçkap, Saadettin; Yalçin, Suayib; Aksoy, Sercan.
Afiliación
  • Yildirim HÇ; Hacettepe University Faculty of Medicine, Department of Medical Oncology, Ankara, Turkey. Electronic address: cagri.yildirim@hacettepe.edu.tr.
  • Mutlu E; Erciyes University Faculty of Medicine, Department of Medical Oncology, Kayseri, Turkey.
  • Chalabiyev E; Hacettepe University Faculty of Medicine, Department of Medical Oncology, Ankara, Turkey.
  • Özen M; Sakarya University Faculty of Medicine, Department of Medical Oncology, Sakarya, Turkey.
  • Keskinkiliç M; 9 Eylül University Faculty of Medicine, Department of Medical Oncology, Izmir, Turkey.
  • Ön S; Ege University Faculty of Medicine, Department of Medical Oncology, Izmir, Turkey.
  • Çelebi A; Marmara University Faculty of Medicine, Department of Medical Oncology, Istanbul, Turkey.
  • Dursun B; Ankara University Faculty of Medicine, Department of Medical Oncology, Ankara, Turkey.
  • Acar Ö; Manisa Celal Bayar University Faculty of Medicine, Department of Medical Oncology, Manisa, Turkey.
  • Kahraman S; Ankara Yildirim Beyazit University Faculty of Medicine, Department of Medical Oncology, Ankara, Turkey.
  • Aykan MB; Gulhane Training and Research Hospital, Department of Medical Oncology, Ankara, Turkey.
  • Kaman Ö; Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Department of Medical Oncology, Ankara, Turkey.
  • Dogan A; Kartal Dr. Lütfi Kirdar City Hospital, Department of Medical Oncology, Istanbul, Turkey.
  • Erdogan AP; Manisa Celal Bayar University Faculty of Medicine, Department of Medical Oncology, Manisa, Turkey.
  • Melisa Celayir Ö; MAA Acibadem University, Department of Medical Oncology, Istanbul, Turkey.
  • Günenç D; Ege University Faculty of Medicine, Department of Medical Oncology, Izmir, Turkey.
  • Güven DC; Hacettepe University Faculty of Medicine, Department of Medical Oncology, Ankara, Turkey.
  • Vedat Bayoglu I; Marmara University Faculty of Medicine, Department of Medical Oncology, Istanbul, Turkey.
  • Yavuzsen T; 9 Eylül University Faculty of Medicine, Department of Medical Oncology, Izmir, Turkey.
  • Hacibekiroglu I; Sakarya University Faculty of Medicine, Department of Medical Oncology, Sakarya, Turkey.
  • Inanç M; Erciyes University Faculty of Medicine, Department of Medical Oncology, Kayseri, Turkey.
  • Kiliçkap S; Istinye University Liv Hospital, Department of Medical Oncology, Ankara, Turkey.
  • Yalçin S; Hacettepe University Faculty of Medicine, Department of Medical Oncology, Ankara, Turkey.
  • Aksoy S; Hacettepe University Faculty of Medicine, Department of Medical Oncology, Ankara, Turkey.
Breast ; 66: 85-88, 2022 Dec.
Article en En | MEDLINE | ID: mdl-36208540

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Neoplasias de la Mama Masculina Tipo de estudio: Clinical_trials Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Breast Asunto de la revista: ENDOCRINOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Neoplasias de la Mama Masculina Tipo de estudio: Clinical_trials Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Breast Asunto de la revista: ENDOCRINOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article Pais de publicación: Países Bajos